Trials / Conditions / Immunodeficiencies

Immunodeficiencies

18 registered clinical trials studyying Immunodeficiencies — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency NCT06954441	On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.	Phase 3
Completed	COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations NCT04852276	National Institute of Allergy and Infectious Diseases (NIAID)	—
Active Not Recruiting	Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies NCT02990819	Children's Hospital of Philadelphia	Phase 2
Withdrawn	Novel Testing Procedures NCT01793506	Medical College of Wisconsin	—
Completed	Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) NCT03609814	University of California, San Francisco	—
Completed	Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients NCT03609827	University of California, San Francisco	—
Recruiting	Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC NCT02356653	Children's Hospital of Philadelphia	EARLY_Phase 1
Recruiting	Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) NCT01666080	Masonic Cancer Center, University of Minnesota	N/A
Completed	Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases NCT02277639	Children's Hospital of Philadelphia	Phase 2
Completed	CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant NCT01049854	New York Medical College	Phase 2
Completed	Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation NCT01316549	University of California, San Francisco	—
Completed	Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Di NCT00744692	Duke University	Phase 1
Active Not Recruiting	Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders NCT01050855	Children's Hospital of Philadelphia	Phase 2
Terminated	Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders NCT00801931	Columbia University	Phase 1 / Phase 2
Completed	CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Dep NCT00579124	Children's Hospital of Philadelphia	Phase 2
Terminated	Unrelated Donor Transplant for Malignant and Non-Malignant Disorders NCT01050439	Columbia University	Phase 2
Recruiting	Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Livi NCT00001281	National Institute of Allergy and Infectious Diseases (NIAID)	—
Available	Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC NCT03145545	Children's Hospital of Philadelphia	—